Sunday, June 28, 2009 9:48:57 PM
Re: INSM:
Of technical interest, INSM fell to its bullish channel's midline level drawn last APR 09 - This is not a dead stock, since it contains several investigational drugs in its pipeline, but recent news regarding its most awaited drug (ALS recomb DNA modulator I believe - not strong or interested in fundies myself), failed to please the institutional investors and the public at-large:
D.
Of technical interest, INSM fell to its bullish channel's midline level drawn last APR 09 - This is not a dead stock, since it contains several investigational drugs in its pipeline, but recent news regarding its most awaited drug (ALS recomb DNA modulator I believe - not strong or interested in fundies myself), failed to please the institutional investors and the public at-large:
D.
More LIVE charts
TA out of Moorea, French Pacific Islands
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
